Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zilli

Showing results (51-60 of 234) with videos related to

Pageof 24
Sort By:
Therapeutic Advances in Medical Oncology|October 28, 2021
Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?Anna Patrikidou, Thomas Zilli, Giulia Baciarello, et al.
Lancet (London, England)|September 18, 2022
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapyFabio Turco, Silke Gillessen, Davide Giovanni Bosetti, et al.
Journal of Cancer Research and Clinical Oncology|March 20, 2019
Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?Vérane Achard, Sandra Jorcano, Michel Rouzaud, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 20, 2014
In vivo quality assurance of volumetric modulated arc therapy for ano-rectal cancer with thermoluminescent dosimetry and image-guidanceGiovanna Dipasquale, Philippe Nouet, Michel Rouzaud, et al.
American Journal of Clinical Oncology|January 10, 2018
Oligorecurrent Nodal Prostate Cancer: Long-term Results of an Elective Nodal Irradiation ApproachSebastien Tran, Sandra Jorcano, Teresa Falco, et al.
Technology in Cancer Research & Treatment|April 4, 2014
Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton TherapyHansjörg Vees, Giovanna Dipasquale, Philippe Nouet, et al.
Translational Cancer Research|November 16, 2023
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple "MIRAGE"?Davide Giovanni Bosetti, Antonio Angrisani, Francesco Mosè Castronovo, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2023
The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A reviewRand N Wilcox Vanden Berg, Thomas Zilli, Vérane Achard, et al.
Cancers|September 28, 2024
Oligometastatic Urothelial Cancer and Stereotactic Body Radiotherapy: A Systematic Review and an Updated Insight of Current Evidence and Future DirectionsAntonio Angrisani, Davide Giovanni Bosetti, Ursula Maria Vogl, et al.
Revue Medicale Suisse|March 15, 2018
[Sexual health after radiotherapy]Francesca Caparrotti, Odile Fargier-Bochaton, Melpomeni Kountouri, et al.
Pageof 24

Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Therapeutic Advances in Medical Oncology|October 28, 2021
Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?Anna Patrikidou, Thomas Zilli, Giulia Baciarello, et al.
Lancet (London, England)|September 18, 2022
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapyFabio Turco, Silke Gillessen, Davide Giovanni Bosetti, et al.
Journal of Cancer Research and Clinical Oncology|March 20, 2019
Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?Vérane Achard, Sandra Jorcano, Michel Rouzaud, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 20, 2014
In vivo quality assurance of volumetric modulated arc therapy for ano-rectal cancer with thermoluminescent dosimetry and image-guidanceGiovanna Dipasquale, Philippe Nouet, Michel Rouzaud, et al.
American Journal of Clinical Oncology|January 10, 2018
Oligorecurrent Nodal Prostate Cancer: Long-term Results of an Elective Nodal Irradiation ApproachSebastien Tran, Sandra Jorcano, Teresa Falco, et al.
Technology in Cancer Research & Treatment|April 4, 2014
Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton TherapyHansjörg Vees, Giovanna Dipasquale, Philippe Nouet, et al.
Translational Cancer Research|November 16, 2023
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple "MIRAGE"?Davide Giovanni Bosetti, Antonio Angrisani, Francesco Mosè Castronovo, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2023
The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A reviewRand N Wilcox Vanden Berg, Thomas Zilli, Vérane Achard, et al.
Cancers|September 28, 2024
Oligometastatic Urothelial Cancer and Stereotactic Body Radiotherapy: A Systematic Review and an Updated Insight of Current Evidence and Future DirectionsAntonio Angrisani, Davide Giovanni Bosetti, Ursula Maria Vogl, et al.
Revue Medicale Suisse|March 15, 2018
[Sexual health after radiotherapy]Francesca Caparrotti, Odile Fargier-Bochaton, Melpomeni Kountouri, et al.
Pageof 24